BSECompany Update1d ago · 17 Nov 2026, 05:13 pm

Schedule of Investor Meet Intimation

Gland Pharma Ltd · 543245

✦ AI SummaryMgmt Change

Gland Pharma Ltd has announced the schedule of analyst/institutional investor meetings, including a one-on-one meeting with ADIA on November 20, 2026. The schedule is subject to change due to exigencies.

Analysis Scores

Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact8/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation